Their ability to lower serum cholesterol and triglyceride levels, reduce liver fat content, and decrease the highly inflammatory visceral fat means that while these drugs are producing weight loss, theyre making a big impact on inflammation and metabolism
General guidelines and dosing for patients with T2D: Initiate pramlintide at the 60 mcg dose taken immediately prior to major meals Titrate pramlintide to 120 mcg dose after 3 or more days with no clinically significant nausea Optimize insulin to achieve glycemic targets once the maintenance dose of pramlintide is reached and blood glucose concentrations are stable Practical Tips for Patients On Pramlintide Start With a Low Dose and Titrate Slowly Pramlintide can cause nausea, anorexia and vomiting, especially in T1D where a more gradual titration is required
Talk to your provider about adjusting your dose, slowing your titration schedule, or helping you switch medications
Upper right abdominal pain, fever, or yellowing of skin/eyes : These may indicate gallbladder disease, which occurs at higher rates in patients taking GLP-1 medications
(Click here for the link to the DoD Component CISO List)
Different tests check for different toxins
